LFG
BSX icon

Larson Financial Group’s Boston Scientific BSX Stock Holding History

Larson Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$999K Sell
23,409
-40,209
-63% -$2.18M 0.03% 365
2026
Q1 		$3.99M Buy
63,618
+1,902
+3% +$152K 0.13% 144
2025
Q4 		$5.88M Sell
61,716
-2,929
-5% -$287K 0.2% 92
2025
Q3 		$6.31M Buy
64,645
+1,308
+2% +$135K 0.22% 87
2025
Q2 		$6.8M Buy
63,337
+8,781
+16% +$888K 0.27% 85
2025
Q1 		$5.5M Buy
54,556
+2,147
+4% +$216K 0.26% 76
2024
Q4 		$4.68M Buy
52,409
+4,599
+10% +$405K 0.24% 83
2024
Q3 		$4.01M Buy
47,810
+1,710
+4% +$135K 0.23% 89
2024
Q2 		$3.55M Buy
46,100
+1,517
+3% +$111K 0.24% 76
2024
Q1 		$3.05M Sell
44,583
-1,036
-2% -$66.6K 0.24% 81
2023
Q4 		$2.64M Sell
45,619
-390
-0.8% -$20.8K 0.23% 80
2023
Q3 		$2.43M Buy
46,009
+1,450
+3% +$76K 0.24% 78
2023
Q2 		$2.41M Sell
44,559
-523
-1% -$27.3K 0.24% 79
2023
Q1 		$2.26M Buy
45,082
+1,265
+3% +$59.6K 0.25% 83
2022
Q4 		$2.03M Buy
43,817
+94
+0.2% +$4.07K 0.24% 84
2022
Q3 		$1.69M Buy
43,723
+42,492
+3,452% +$1.7M 0.24% 73
2022
Q2 		$46K Buy
1,231
+616
+100% +$25.1K 0.01% 385
2022
Q1 		$27K Buy
615
+227
+59% +$9.84K ﹤0.01% 476
2021
Q4 		$16K Hold
388
– – ﹤0.01% 589
2021
Q3 		$17K Hold
388
– – ﹤0.01% 495
2021
Q2 		$17K Hold
388
– – ﹤0.01% 461
2021
Q1 		$15K Hold
388
– – ﹤0.01% 461
2020
Q4 		$14K Hold
388
– – ﹤0.01% 431
2020
Q3 		$15K Hold
388
– – 0.01% 370
2020
Q2 		$14K Hold
388
– – 0.01% 326
2020
Q1 		$13K Hold
388
– – 0.01% 259
2019
Q4 		$18K Hold
388
– – 0.01% 230
2019
Q3 		$16K Hold
388
– – 0.01% 245
2019
Q2 		$17K Hold
388
– – 0.01% 200
2019
Q1 		$15K Hold
388
– – 0.01% 197
2018
Q4 		$14K Buy
+388
New +$14.1K 0.01% 189

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Larson Financial Group's BSX Position: Q2 2026 in Review

Larson Financial Group reduced its Boston Scientific (BSX) stake by 63% in Q2 2026, selling an estimated $2.18M and leaving 23,409 shares worth $999K. The position accounts for 0.03% of the portfolio, ranked #365.

Larson Financial Group first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.8M in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Larson Financial Group held 23,409 shares of Boston Scientific worth $999K as of Q2 2026.
  • Larson Financial Group sold 40,209 Boston Scientific shares in Q2 2026, an estimated $2.18M.
  • Boston Scientific made up 0.03% of Larson Financial Group's portfolio in Q2 2026, its #365 holding.
  • Larson Financial Group first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
  • Larson Financial Group's Boston Scientific position peaked at $6.8M in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.